Literature DB >> 11064674

Cell proliferation in type C gastritis affecting the intact stomach.

J E Dowall1, P Willis, R Prescott, S Lamonby, D A Lynch.   

Abstract

AIMS: Type C gastritis caused by bile reflux has a characteristic appearance, similar to that seen in other forms of chemical gastritis, such as those associated with NSAIDs or alcohol. An increase in mucosal cell proliferation increases the likelihood of a neoplastic clone of epithelial cells emerging, particularly where there is chronic epithelial injury associated with bile reflux. It has been shown previously that type C gastritis is associated with increased cell proliferation in the postsurgical stomach. The aim of this study was to determine cell proliferation in type C gastritis caused by bile reflux affecting the intact stomach.
METHODS: Specimens from 15 patients with a histological diagnosis of type C gastritis on antral biopsy were obtained from the pathology archives between 1994 and 1997. A control group of nine normal antral biopsies was also selected and all underwent MIB-1 immunostaining. The gastric glands were divided into three zones (zone 1, gastric pit; zone 2, isthmus; and zone 3, gland base) and the numbers of positively staining nuclei for 500 epithelial cell nuclei were counted in each zone to determine the percentage labelling index (LI%).
RESULTS: Cell proliferation was significantly higher in all three zones of the gastric glands with type C gastritis compared with controls as follows: zone 1, median LI% in type C gastritis 64.7 (range, 7.8-99.2), controls 4.7 (range, 2.0-11.3); zone 2, median LI% in type C gastritis 94.7 (range, 28.8-98.7), controls 40.2 (range, 23.1-70.3); and zone 3, median LI% in type C gastritis 20.0 (range, 1.3-96.0), controls 2.6 (range, 0.9-8.7).
CONCLUSIONS: Bile reflux is thought to act as a promoter of gastric carcinogenesis in the postsurgical stomach. The same may be true in the intact stomach.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11064674      PMCID: PMC1731098          DOI: 10.1136/jcp.53.10.784

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  18 in total

1.  Role of Helicobacter pylori infection and duodenogastric reflux in the pathogenesis of alkaline reflux gastritis after gastric operations.

Authors:  R Robles-Campos; J A Lujan-Mompean; P Parrilla-Paricio; J Bermejo-Lopez; R Liron-Ruiz; J A Torralba-Martinez; G Morales-Cuenca; J A Molina-Martinzez
Journal:  Surg Gynecol Obstet       Date:  1993-06

2.  Gastric cell proliferation kinetics and bile reflux after partial gastrectomy.

Authors:  P Bechi; M Balzi; A Becciolini; A Amorosi; E Scubla; V Giachè; R Mazzanti; P Tonelli; C Cortesini
Journal:  Am J Gastroenterol       Date:  1991-10       Impact factor: 10.864

3.  Bile reflux and intestinal metaplasia in gastric mucosa.

Authors:  G M Sobala; H J O'Connor; E P Dewar; R F King; A T Axon; M F Dixon
Journal:  J Clin Pathol       Date:  1993-03       Impact factor: 3.411

4.  Gastric foveolar hyperplasia in patients with cancer of the intact stomach.

Authors:  S Rakic; J Bandovic; M Dunjic; T Randjelovic
Journal:  Surg Laparosc Endosc       Date:  1994-06

5.  Gastric carcinogenesis in the rat induced by duodenogastric reflux without carcinogens: morphology, mucin histochemistry, polyamine metabolism, and labelling index.

Authors:  P R Taylor; R C Mason; M I Filipe; S Vaja; D C Hanley; G M Murphy; R H Dowling; I McColl
Journal:  Gut       Date:  1991-12       Impact factor: 23.059

Review 6.  Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention.

Authors:  P Correa
Journal:  Cancer Res       Date:  1992-12-15       Impact factor: 12.701

7.  Effect of eradication of Helicobacter pylori on gastric epithelial cell proliferation.

Authors:  A G Fraser; R Sim; E A Sankey; A P Dhillon; R E Pounder
Journal:  Aliment Pharmacol Ther       Date:  1994-04       Impact factor: 8.171

8.  Different bile acids exhibit distinct biological effects: the tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation.

Authors:  J D Martinez; E D Stratagoules; J M LaRue; A A Powell; P R Gause; M T Craven; C M Payne; M B Powell; E W Gerner; D L Earnest
Journal:  Nutr Cancer       Date:  1998       Impact factor: 2.900

9.  Intragastric bile acids and histological changes in gastric mucosa.

Authors:  P W Houghton; N J Mortensen; W E Thomas; M J Cooper; A P Morgan; P Burton
Journal:  Br J Surg       Date:  1986-05       Impact factor: 6.939

10.  Comparison of labelling by bromodeoxyuridine, MIB-1, and proliferating cell nuclear antigen in gastric mucosal biopsy specimens.

Authors:  D A Lynch; A M Clarke; P Jackson; A T Axon; M F Dixon; P Quirke
Journal:  J Clin Pathol       Date:  1994-02       Impact factor: 3.411

View more
  4 in total

1.  Orthotopic transplantation model of human gastrointestinal cancer and detection of micrometastases.

Authors:  J H Cui; U Krueger; D Henne-Bruns; B Kremer; H Kalthoff
Journal:  World J Gastroenterol       Date:  2001-06       Impact factor: 5.742

2.  On-chip lectin microarray for glycoprofiling of different gastritis types and gastric cancer.

Authors:  Bibhas Roy; Gautam Chattopadhyay; Debasish Mishra; Tamal Das; Suman Chakraborty; Tapas K Maiti
Journal:  Biomicrofluidics       Date:  2014-06-06       Impact factor: 2.800

3.  Indefinite for non-invasive neoplasia lesions in gastric intestinal metaplasia: the immunophenotype.

Authors:  Mauro Cassaro; Massimo Rugge; Chiara Tieppo; Luciano Giacomelli; Daniela Velo; Donato Nitti; Fabio Farinati
Journal:  J Clin Pathol       Date:  2007-06       Impact factor: 3.411

Review 4.  Plant Lectins as Medical Tools against Digestive System Cancers.

Authors:  Laura Elena Estrada-Martínez; Ulisses Moreno-Celis; Ricardo Cervantes-Jiménez; Roberto Augusto Ferriz-Martínez; Alejandro Blanco-Labra; Teresa García-Gasca
Journal:  Int J Mol Sci       Date:  2017-07-03       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.